A 2026 informational report on Triple Green Farms CBD Gummies' full spectrum hemp extract formula, how the endocannabinoid ...
Jazz Pharmaceuticals stock pops as President Trump signals renewed urgency to reclassify cannabis as Schedule III drug.
HealthDay on MSN
Tween, teen cannabis use linked to slower cognitive development
Youth cannabis use between ages 9 and 17 years is associated with slower cognitive development during a time of key brain ...
A string of ASX-listed drug developers is due to release company-making – or breaking – pivotal clinical study results in ...
The order instructs the FDA to expedite review of drugs such as ibogaine, a drug that veterans' groups have said can help ...
A Neuropsychopharmacology Circumspectives article argues that cannabidiol has genuine therapeutic potential, especially in ...
Rachel Carr Shreves and Crystal Howard of Spencer Fane discuss the proposed federal rescheduling of cannabis to Schedule III ...
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will present six abstracts, including one oral presentation, at the 2026 American Academy of Neurology (AAN) Annual Meeting, ...
According to 2025 data from the National Conference of State Legislatures (NCSL), medical marijuana is legal in 40 states and ...
A new UC San Diego study strengthens the growing body of evidence that marijuana use impacts adolescent brain development.
Carnival Cruise Line has updated its onboard prohibited items policy, with brand ambassador John Heald highlighting new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results